Crestline Management, LP Iovance Biotherapeutics, Inc. Transaction History

Crestline Management, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 14, 2018	SELL	$12.45 - $16.95 $1.16 Million - $1.58 Million	-93,346 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$8.1 - $19.5 $756,102 - $1.82 Million	93,346 New	93,346 $1.58 Million
Q3 2017 Nov 14, 2017	SELL	$4.45 - $8.55 $192,480 - $369,821	-43,254 Closed	0 $0
Q2 2017 Aug 14, 2017	BUY	N/A	43,254	43,254 $318,000

313

241M

3.77M

1.7M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.28B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Crestline Management, LP, based on Form 13F filings with the SEC.

Stay updated on Crestline Management, LP with notifications on news.